Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Solasto Corp. ( (JP:6197) ) just unveiled an update.
Solasto Corporation has announced a new corporate officer structure, effective April 1, 2026, following recommendations from its Nomination, Evaluation, and Compensation Committee and approval by the Board of Directors. President and CEO Toru Noda will continue as Chief Executive Officer, while senior and managing corporate officers are assigned to key roles overseeing IT strategy and business development, medical services, elderly care operations, and management functions. The company is also creating a Business Operations Division, underscoring a push toward more integrated, IT-driven and efficient business management, which is likely aimed at strengthening operational oversight and supporting future growth in its medical and elderly care businesses.
The most recent analyst rating on (JP:6197) stock is a Buy with a Yen867.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.
More about Solasto Corp.
Solasto Corporation is a Japan-based company listed on the Tokyo Stock Exchange Prime Market that operates in the medical and elderly care services industry. The company focuses on managing medical-related businesses, including its Medical Business Division, and providing elderly care services through its Elderly Care Business Division, while also emphasizing IT strategy and smart operations to support business development.
Average Trading Volume: 934,315
Technical Sentiment Signal: Buy
Current Market Cap: Yen81.48B
Learn more about 6197 stock on TipRanks’ Stock Analysis page.

